Kendle announced Thursday that the company has received approval from Indian authorities to proceed with development of a new operations center in a Special Economic Zone (SEZ) in the upcoming Ahmedabad-Gandhinagar Knowledge Corridor.

Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, reported its results for the fourth quarter and full-year 2009. Net

Recently, Scrip Clinical Research, a news and analysis service for the global pharmaceutical industry, interviewed Simon Higginbotham, senior vice-president and chief marketing officer of Cincinnati-based Kendle.

Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, reported solid net income of $8.8 million or $0.59 per diluted share for the third quarter of 2009.